MRK Merck & Company Inc

USD 78.74 -0.23 ( -0.29%)
Icon

Merck & Company Inc (MRK) Financial Statements

COMMON STOCK | Drug Manufacturers - General | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 78.74

-0.23 (-0.29%)

N/A

0.02B

USD 116.71(+48.22%)

USD 103.04 (+30.86%)

Icon

MRK

Merck & Company Inc (USD)
COMMON STOCK | NYE
USD 78.74
-0.23 ( -0.29%)

Merck & Company Inc (MRK) Annual Income Statement (USD)

MRK Quarterly Financials (USD)

Frequently Asked Questions About Merck & Company Inc (MRK) Stock

Merck & Company Inc's (MRK) last reported annual revenue was USD 59.87 Billion.

Merck & Company Inc's (MRK) annual revenue growth rate based on the revenue reported in the past 5 years is : 7.20%

Merck & Company Inc's(MRK) is profitable as of its last reported annual financials.

The net profit margin for Merck & Company Inc's(MRK) from its laster reported year is 0.61%

The return on equity (ROE) for Merck & Company Inc's(MRK) from its last reported annual financials is : N/A

The return on assets (ROA) for Merck & Company Inc's(MRK) from its last reported annual financials is : N/A

The return on invested capital (ROIC) for Merck & Company Inc's(MRK) from its last reported annual financials is : N/A

The Debt to Equity ratio for Merck & Company Inc's(MRK) from its last reported annual financials is : N/A

The dividend yield for Merck & Company Inc's(MRK) from its laster reported year is N/A

Merck & Company Inc's(MRK) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...